Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab

Eosinophilic granulomatosis with polyangiitis (EGPA) in association with the use of asthma medications has been reported. We report the first Asian case of EGPA developed after dupilumab administration in a 77-year-old Japanese woman and discuss the association between dupilumab and EGPA.

Detalles Bibliográficos
Autores principales: Yamazaki, Kai, Nomizo, Takafumi, Hatanaka, Kazuhito, Hayama, Naoki, Oguma, Tsuyoshi, Asano, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509859/
https://www.ncbi.nlm.nih.gov/pubmed/37781267
http://dx.doi.org/10.1016/j.jacig.2022.03.006
_version_ 1785107844935188480
author Yamazaki, Kai
Nomizo, Takafumi
Hatanaka, Kazuhito
Hayama, Naoki
Oguma, Tsuyoshi
Asano, Koichiro
author_facet Yamazaki, Kai
Nomizo, Takafumi
Hatanaka, Kazuhito
Hayama, Naoki
Oguma, Tsuyoshi
Asano, Koichiro
author_sort Yamazaki, Kai
collection PubMed
description Eosinophilic granulomatosis with polyangiitis (EGPA) in association with the use of asthma medications has been reported. We report the first Asian case of EGPA developed after dupilumab administration in a 77-year-old Japanese woman and discuss the association between dupilumab and EGPA.
format Online
Article
Text
id pubmed-10509859
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105098592023-09-29 Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab Yamazaki, Kai Nomizo, Takafumi Hatanaka, Kazuhito Hayama, Naoki Oguma, Tsuyoshi Asano, Koichiro J Allergy Clin Immunol Glob Case Report Eosinophilic granulomatosis with polyangiitis (EGPA) in association with the use of asthma medications has been reported. We report the first Asian case of EGPA developed after dupilumab administration in a 77-year-old Japanese woman and discuss the association between dupilumab and EGPA. Elsevier 2022-04-30 /pmc/articles/PMC10509859/ /pubmed/37781267 http://dx.doi.org/10.1016/j.jacig.2022.03.006 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Yamazaki, Kai
Nomizo, Takafumi
Hatanaka, Kazuhito
Hayama, Naoki
Oguma, Tsuyoshi
Asano, Koichiro
Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab
title Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab
title_full Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab
title_fullStr Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab
title_full_unstemmed Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab
title_short Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab
title_sort eosinophilic granulomatosis with polyangiitis after treatment with dupilumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509859/
https://www.ncbi.nlm.nih.gov/pubmed/37781267
http://dx.doi.org/10.1016/j.jacig.2022.03.006
work_keys_str_mv AT yamazakikai eosinophilicgranulomatosiswithpolyangiitisaftertreatmentwithdupilumab
AT nomizotakafumi eosinophilicgranulomatosiswithpolyangiitisaftertreatmentwithdupilumab
AT hatanakakazuhito eosinophilicgranulomatosiswithpolyangiitisaftertreatmentwithdupilumab
AT hayamanaoki eosinophilicgranulomatosiswithpolyangiitisaftertreatmentwithdupilumab
AT ogumatsuyoshi eosinophilicgranulomatosiswithpolyangiitisaftertreatmentwithdupilumab
AT asanokoichiro eosinophilicgranulomatosiswithpolyangiitisaftertreatmentwithdupilumab

Ejemplares similares